Table 1.
Characteristics of 348 patients new to HIV care enrolled in the iENGAGE study
| N(%) [unless otherwise indicated(*)] | |
|---|---|
| Site | |
| 1 | 145 (42) |
| 2 | 73 (21) |
| 3 | 74 (21) |
| 4 | 56 (16) |
| Male | 275 (79) |
| Race/ethnicity | |
| Black | 217 (62) |
| White | 98 (28) |
| Hispanic | 17 (5) |
| Other | 16 (5) |
| Age, median years (IQR)* | 34 (27, 45) |
| Insurance type | |
| Private | 152 (44) |
| Public | 117 (34) |
| Uninsured | 76 (22) |
| Missing | 3 |
| Log10 viral load copies/mL, median (IQR)* | 4.6 (3.8, 5.1) |
| Drug use, current | |
| Any illicit | 60 (18) |
| Crack/cocaine | 32 (9) |
| Amphetamines | 21 (6) |
| Heroin/opiates | 17 (5) |
| Alcohol use, AUDIT-C score, median (IQR)* | 2 (0, 4) |
| Hazardous use | 114 (33) |
| Missing | 7 |
| PHQ-8 score, median (IQR)* | 6 (3, 11) |
| Moderate major depression (10–19) | 89 (27) |
| Severe major depression (≥20) | 12 (4) |
| Missing | 21 |
| PHQ-Anxiety | |
| Panic symptoms | 72 (21) |
| Panic disorder | 35 (10) |
| Missing | 9 |
| Anxiety AND depression (any) | 51 (16) |
| Anxiety, no depression | 48 (15) |
| Depression, no anxiety | 45 (14) |
| No anxiety, no depression | 176 (55) |
| Missing anxiety or depression | 28 |
| | |
| CD4 cells/μL, median (IQR)* | 344 (174, 554) |
| <200 cells/μL | 108 (31) |
| 200–499 cells/μL | 146 (42) |
| ≥500 cells/μL | 94 (27) |